Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Maravai Lifesciences Holdings (MRVI) over the last 7 years, with Q3 2025 value amounting to $144.7 million.

  • Maravai Lifesciences Holdings' Shares Outstanding (Diluted Average) rose 220.97% to $144.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.7 million, marking a year-over-year increase of 220.97%. This contributed to the annual value of $137.9 million for FY2024, which is 453.84% up from last year.
  • Maravai Lifesciences Holdings' Shares Outstanding (Diluted Average) amounted to $144.7 million in Q3 2025, which was up 220.97% from $144.2 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Shares Outstanding (Diluted Average) high stood at $258.0 million for Q3 2021, and its period low was $96.7 million during Q1 2021.
  • For the 5-year period, Maravai Lifesciences Holdings' Shares Outstanding (Diluted Average) averaged around $178.9 million, with its median value being $143.4 million (2025).
  • Within the past 5 years, the most significant YoY rise in Maravai Lifesciences Holdings' Shares Outstanding (Diluted Average) was 79180.5% (2021), while the steepest drop was 6192.73% (2021).
  • Maravai Lifesciences Holdings' Shares Outstanding (Diluted Average) (Quarter) stood at $257.8 million in 2021, then fell by 0.96% to $255.3 million in 2022, then plummeted by 48.33% to $131.9 million in 2023, then rose by 4.54% to $137.9 million in 2024, then increased by 4.91% to $144.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $144.7 million in Q3 2025, compared to $144.2 million in Q2 2025 and $143.4 million in Q1 2025.